Call Maxine, Mr Gangwani’s private secretary: 07307 267033 · Monday to Friday, 9am to 5pm

Eye health guide

Omnigen Amniotic Membrane: The Revolutionary Eye Treatment for Healing and Pain Relief

In the world of ophthalmology, innovations that improve patient care and speed up recovery
are always welcome. One such innovation is Omnigen Amniotic Membrane, a biological
dressing that’s changing the way we approach the healing of eye surface diseases. Derived
from the human placenta, Omnigen offers a solution for a variety of eye conditions, providing
faster healing, reducing inflammation, and relieving pain. This blog will explore what
Omnigen is, its uses, and why it’s becoming a preferred treatment for eye injuries and
conditions like dry eye and corneal ulcers.

What Is Omnigen Amniotic Membrane?

Omnigen is a sterile, dry, and stable human amniotic membrane that is processed for
use in ophthalmology. It comes from the innermost layer of the placenta, which is rich in
regenerative properties. Omnigen is often used as a biological dressing to treat eye surface
diseases and has proven beneficial in conditions like dry eye, corneal ulcers, and damage
from chemical burns or trauma.


Unlike traditional amniotic membranes that require freezing for storage, Omnigen has been
developed using a patented Tereo process by NuVision Biotherapies, which enables it to
be stored at room temperature, a huge advantage for easy access and quick application.

How Does Omnigen Work?


Omnigen works as a regenerative barrier, protecting damaged tissues while promoting the
healing process. The amniotic membrane is applied directly to the affected area of the eye,
where it:


● Supports tissue healing: The membrane accelerates the repair of damaged corneal
tissues by providing essential growth factors.


● Reduces inflammation: Omnigen soothes inflammation, which is a common
problem in eye diseases like dry eye and corneal ulcers.


● Prevents scarring: The membrane forms a protective layer that prevents scarring,
which can lead to vision problems if left untreated.

Applications of Omnigen Amniotic Membrane

  • Severe Dry Eye:
    For patients with severe dry eye, Omnigen provides much-needed relief by promoting the
    regeneration of the corneal surface. It soothes the irritation caused by the lack of moisture
    and helps restore the eye’s natural protective layer.

  • Corneal Ulcers:
    Corneal ulcers are open sores on the surface of the cornea, often caused by infection or
    trauma. Omnigen is used to promote healing and protect the ulcerated area, reducing the
    risk of complications like scarring and vision loss

  • Chemical Burns:
    Chemical burns can cause significant damage to the cornea and surrounding tissues.
    Omnigen’s regenerative properties aid in tissue repair and help restore the corneal surface,
    reducing the long-term effects of burns.

  • Corneal Damage from Trauma:
    Whether from an accident or surgery, Omnigen can help heal damaged corneal tissue,
    providing faster recovery and reducing the chances of permanent damage.

How Is Omnigen Applied?


The application of Omnigen is relatively straightforward, often performed in an outpatient
setting. The membrane is applied directly to the surface of the eye, where it acts as a
biological dressing. It is typically held in place by a specialised bandage contact lens
known as OmniLenz, which helps keep the membrane in position while allowing the eye to
heal.


In most cases, Omnigen is used for temporary applications, often in combination with
other treatments like lubricating drops or medication. However, it can also be part of
surgical applications when necessary, particularly for severe cases.

Benefits of Omnigen Amniotic Membrane


Omnigen offers numerous benefits to both patients and ophthalmologists:

  • Off-the-Shelf Convenience:
    Unlike other amniotic membranes that need to be frozen, Omnigen can be used
    immediately after opening, making it an excellent “off-the-shelf” solution for treating eye
    diseases without delays.

  • Fast Healing:
    Patients experience faster recovery times due to the regenerative properties of the
    membrane. By promoting cell growth and tissue repair, it helps reduce the severity and
    duration of symptoms like inflammation and irritation.

  • Reduced Inflammation and Pain Relief:
    Omnigen’s ability to reduce inflammation makes it invaluable for patients suffering from
    chronic eye diseases like dry eye or acute injuries like corneal ulcers. It also provides pain
    relief, allowing patients to feel more comfortable as they heal.

  • Prevention of Scarring:
    The protective barrier formed by Omnigen prevents the formation of scar tissue, which can
    affect vision and lead to long-term complications if not managed properly.

Regulation and Safety


In the UK, Omnigen is regulated by the Human Tissue Authority (HTA), ensuring that it
meets high standards of safety and quality. This regulation assures healthcare professionals
and patients that Omnigen is a safe and effective treatment option for eye surface diseases.

Omnigen amniotic membrane is a groundbreaking advancement in the treatment of eye
surface diseases, offering a fast, effective, and convenient solution to conditions like dry eye,
corneal ulcers, and injuries caused by chemical burns or trauma. With its regenerative
properties, ability to reduce inflammation, and promote faster healing, Omnigen is
making a significant impact in ophthalmology.


If you or someone you know suffers from any of the conditions listed above, Omnigen could
be the treatment that speeds up recovery and provides much-needed relief. Speak with your
ophthalmologist to see if this innovative treatment could benefit your eye health.

If you would like to know whether amniotic membrane treatment could help your eye condition, book a consultation with Mr Gangwani.

About the author

Mr Vinod Gangwani FRCS, MRCOphth

Consultant ophthalmic surgeon and clinical lead for cataract microsurgery at Ashford and St Peter’s NHS Foundation Trust. Fellowship-trained at Moorfields Eye Hospital in cataract and refractive lens surgery and in corneal disease. GMC 6026332.

More guides

Talk it through with Mr Gangwani

Initial consultation £250 at the hospital or clinic nearest to you, usually within two weeks.